Life Sciences IP Review

07/02/2025

Last chance to save $700!

The super early bird discount for LSPN North America–Spring 2025 ends tomorrow! Don't miss your opportunity to join 300+ IP leaders on May 6-7 in Boston for two days of high-level discussions and networking.

At LSPN North America–Spring, you'll hear from industry-leading experts from Merck, Regeneron, The Broad Institute, Beam Therapeutics, Ipsen, Editas Med, and many more as they tackle the most pressing IP challenges in life sciences, including:

💡 §112 post-Amgen v. Sanofi – What does it mean for enablement?
💡 AI & big data in IP – How are innovations being protected?
💡 Evergreening & life cycle management – Managing patents beyond the basics
💡 Patent eligibility (35 U.S.C. §101) – The complexities of diagnostics, AI, and software
💡 Pharmaceutical collaborations – Best practices for structuring partnerships

With exclusive insights, expert-led discussions, and an audience packed with key decision-makers, this is a must-attend event for anyone in life sciences IP.

Register by tomorrow to save $700! Secure your spot now https://ow.ly/H0SR50UT47B!

04/02/2025

Kilpatrick has strengthened its chemistry and life sciences team with the addition of Melissa Harwood, a seasoned IP expert in biotechnology, therapeutics, and chemical industries.

“Our outstanding chemistry and life sciences team has been looking to strategically expand its presence on the West Coast, including in the firm’s Seattle office,” said Roger Wylie, Kilpatrick’s managing partner.

Discover how her expertise will shape the firm’s strategy: https://ow.ly/3qoA50UTuZv

Kilpatrick expands Seattle office with patent partner

04/02/2025

Bristows has appointed renowned patent litigator Naoise Gaffney as UPC director, bringing nearly 20 years of expertise in patent law to its Dublin office.

“Naoise’s industry expertise and strategic vision align perfectly with our goals and those of our clients, and we are confident that this addition will further strengthen our ability to serve our clients, particularly at the UPC.” said Andrew Bowler, head of patent litigation at Bristows.

Find out what this means for the firm’s UPC practice: https://ow.ly/qI9G50UTuPp

Bristows appoints Irish patent attorney to boost UPC representation

04/02/2025

WIPR has unveiled its first USA Patents Rankings, highlighting the top firms and attorneys leading patent prosecution, litigation, and strategy in the US.

The list distinguishes experts in both contentious and non-contentious work, recognizing those shaping the future of patent law.

See who made the cut in this definitive ranking: https://ow.ly/9mAR50UTuAj

New national rankings recognise top US patent firms and lawyers

04/02/2025

Regeneron has secured another victory in its battle to protect Eylea, with the Federal Circuit upholding injunctions that block biosimilar launches from Samsung Bioepis and Formycon.

Judges backed a lower court’s ruling that Regeneron is likely to succeed in its patent infringement claims.

Dive into the details of this high-stakes patent battle: https://ow.ly/Y6fj50UTupf

Regeneron holds off copies of $6bn eye treatment

04/02/2025

LSPN North America–Spring 2025 is shaping up to be our biggest event yet!

Join us May 6-7 in Boston for two days of cutting-edge discussions with top IP professionals in life sciences.

Just confirmed speakers:
✅ Jocelyn Ram & Nicole Mastrangelo (The Broad Institute)
✅ Robert Chang (Amylyx Pharmaceuticals)
✅ Nicole Clouse (Generate Biomedicines)

Key panels to watch:
Beyond Patents: The Evolving Role of IP Lawyers in Life Sciences – featuring IP leaders from Beam Therapeutics, Editas Med & more.
Mastering §112 in the New Era of Life Sciences Patents – expert insights on how new USPTO guidelines are reshaping strategies.

Top IP firms & sponsors confirmed: JMIN, Sterlington, Mewburn & Ellis, Carpmaels & Ransford, Taylor Wessing + 25 more!
Delegates already registered from Merck, Regeneron, Mintz, and The Broad Institute.

72 hours left to grab super early bird pricing—save $750 on your ticket!

Secure your spot now https://ow.ly/WwJl50UT3JB

03/02/2025

LSPN Awards USA 2025 Deadline Extended!

Due to high demand, we’ve extended the entry deadline to midday BST on Friday, February 14—but time is running out!

🎖 Showcase your expertise in life sciences IP
🎖 Nominate a firm or individual making a real impact
🎖 Join us in Boston on May 6 for the Awards Ceremony

With 100+ entries already received, don’t miss your chance to be recognized among the best in the industry!

Submit your entry today https://ow.ly/m2IW50US9VO

31/01/2025

Fish & Richardson is making a bold move into the Midwest with a new Chicago office, set to become its 15th hub for IP services.

John Adkisson, president and CEO at Fish & Richardson, said: “Chicago has long been a hub of Fish activity. It’s a natural next step to offer an office to support local colleagues and clients,” he added.

Find out what this expansion means for the firm and its clients: https://ow.ly/v2l350UQQ7b

Fish & Richardson doubles down in Chicago with new office

31/01/2025

GSK is urging a Delaware judge to increase its $235 million award in a decade-long patent battle with Teva, while Teva fights for a new trial.

The case centers on the controversial ‘skinny label’ strategy used by generic drug makers.

Discover the latest twists in this high-stakes legal fight: https://ow.ly/YWPj50UQPX3

GSK seeks damages hike in ‘skinny label’ case

31/01/2025

The UK Court of Appeal has ruled against MSD’s SPC application for Cladribine, affirming that UK courts must follow EU precedent even post-Brexit.

The decision reinforces the ongoing influence of the CJEU in UK patent law.

Explore the implications of this ruling for SPC law: https://ow.ly/vewU50UQPTA

UK court upholds EU SPC precedent, rejecting MSD’s appeal

29/01/2025

Goodwin has strengthened its life sciences practice with the addition of patent expert Carl Morales as a partner in New York.

Mitchell Bloom, global chair of life sciences at Goodwin, said: “Intellectual property is central to innovation and growth, particularly in life sciences.”

Find out how his expertise will impact the firm’s portfolio strategy: https://ow.ly/nF3R50UPnuJ

Goodwin hires ‘impressive’ partner for NY office

29/01/2025

Munck Wilson Mandala has bolstered its Houston office with the hire of biotech patent litigation expert Merritt Westcott as an IP partner.

John Cain, managing partner of MWM’s Houston office, said: “Merritt’s experience handling high-stakes cases and her deep technical background will complement our firm’s focus on providing sophisticated IP solutions to clients in a variety of sectors.”

Discover what her appointment means for the firm: https://ow.ly/Z9GQ50UPnpb

Munck Wilson Mandala brings in first-chair patent litigator from McGuireWoods

29/01/2025

The UPC has flagged “deficiencies” in Sanofi’s patent infringement case against four generics makers over its prostate cancer drug, Jevtana, citing unclear territories and https://ow.ly/cVc250UPnlk acts of infringement.

This setback follows years of legal battles over generic competition and a recent patent revocation in France.

See what this means for the case ahead: https://www.lifesciencesipreview.com/europe/upc-orders-sanofi-to-fix-deficiencies-in-prostate-cancer-drug-case

UPC orders Sanofi to fix ‘deficiencies’ in prostate cancer drug case

29/01/2025

A Dutch court has invalidated Biogen’s patent for its MS drug Tecfidera, ruling that its 480mg dosage lacked inventiveness.

While this opens the door for generics, key challengers remain barred from the Dutch market until February 3.

Explore the implications of this decision: https://ow.ly/KojT50UPnck

Dutch court axes Biogen’s MS patent, clearing way for generics

28/01/2025

Nominations close this Friday for the LSPN Awards USA 2025!

With just 4 days left to enter, now’s your chance to gain recognition for your outstanding achievements in pharmaceutical and biotech patent protection.

Choose your category and complete the entry form by Friday, January 31, 2025, to be in with a chance to win!

🏆Company Award Categories Include:
Life Sciences IP Firm of the Year
Emerging Firm/One to Watch
IP Boutique of the Year
In-House Team of the Year
Excellence in Patent Licensing and Transactions
Technology Solution of the Year – Patents
And many more!

Check out the full list of categories and submit your entry now: https://ow.ly/CGEA50UNzWw

Our esteemed judging panel includes:
Mark Stewart, VP, Global IP Litigation, Merck
Karen Martin, Senior VP & Chief IP Counsel, Ipsen
David Gindler, Partner, Orrick
Jennifer Burdman, Managing Director, Sauvegarder Investment Management
Eldora Ellison, Director, Sterne Kessler

Don’t miss out—celebrate your achievements at the Awards Gala Dinner in Boston on May 6, 2025!

22/01/2025

The IP Federation has opposed a proposed ban on in-house lawyers representing employers before the Unified Patent Court (UPC), warning it could harm SMEs and limit options for in-house patent attorneys.

On January 29, the UPC Court of Appeal will address this contentious interpretation of representative independence.

Explore the potential impact on the patent profession: https://ow.ly/hh5p50UKOUj

IP Federation warns against ‘blanket ban’ on in-house counsel at UPC

22/01/2025

On his inauguration day, President Donald Trump repealed Executive Order 14087, which sought to lower prescription drug costs, marking a dramatic pivot in US healthcare policy.

Calling the order "inflationary, illegal, and radical," Trump vowed this would be the first of many steps to "repair our institutions and economy."

Discover the implications of this policy reversal: https://ow.ly/o6AU50UKOTk

Trump nixes Biden’s Executive Order on drug pricing

20/01/2025

Are you shaping the future of life sciences IP?

The 2025 Life Sciences Patent Network Awards are on the hunt for the legal minds behind groundbreaking biotech, pharmaceutical, and medical device patents.

We’re celebrating attorneys who excel in:
🔹 Strategic brilliance in patent prosecution
🔹 Industry-defining portfolio management
🔹 Innovative solutions to emerging challenges in AI, gene editing, and precision medicine

Nominations close January 31. Don’t miss your chance to be recognized as a leader in life sciences IP innovation.

Enter now! https://ow.ly/slZ750UJnmQ